(PATH) Uipath - Ratings and Ratios
Automation, RPA, Workflow, AI, Cloud-Based
PATH EPS (Earnings per Share)
PATH Revenue
Description: PATH Uipath
UiPath Inc. is a leading provider of robotic process automation (RPA) solutions, offering an end-to-end automation platform that enables organizations to automate repetitive tasks with precision and speed. The companys software robots emulate human actions, leveraging embedded AI, ML, and NLP capabilities to improve decision-making and information processing. UiPaths platform allows users to design and combine UI automations, API integrations, and AI-based document understanding in a single workflow, making it a comprehensive solution for businesses across various industries, including financial services, healthcare, manufacturing, retail, and public sector.
UiPaths Automation Cloud enables rapid automation without infrastructure overhead, while its intuitive interface and low-code, drag-and-drop functionality make it accessible to users without extensive technical expertise. The companys mining capabilities analyze the digital footprint of users processes, providing actionable metrics and predictive insights to optimize business processes and maximize return on investment. With its focus on enabling people and automations to work together, UiPath aims to enhance productivity and improve business outcomes.
From a technical standpoint, UiPaths stock (PATH) has shown a bullish trend, with its short-term and long-term moving averages indicating a potential upward momentum. The stock is currently trading above its 20-day and 50-day simple moving averages (SMA20: 12.85, SMA50: 11.73), and its average true range (ATR: 0.44 = 3.37%) suggests moderate volatility. Given the current price (13.21) and its proximity to the 52-week high (15.50), we can forecast a potential target price of 16.50 in the next 6-12 months, driven by the companys strong fundamentals and growth prospects.
UiPaths fundamental data indicates a market capitalization of approximately $6.98 billion, with a forward price-to-earnings ratio of 24.15. Although the company is currently operating at a loss (RoE: -3.96), its investment in growth initiatives and expansion into new markets is expected to drive future profitability. As the RPA market continues to grow, UiPath is well-positioned to capitalize on this trend, driven by its comprehensive platform, strong industry partnerships, and commitment to innovation. Our forecast is based on the analysis of the companys technical and fundamental data, indicating a potential upside in the stock price as the company continues to execute on its growth strategy.
Additional Sources for PATH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PATH Stock Overview
Market Cap in USD | 6,544m |
Sector | Technology |
Industry | Software - Infrastructure |
GiC Sub-Industry | Systems Software |
IPO / Inception | 2021-04-21 |
PATH Stock Ratings
Growth Rating | -60.8 |
Fundamental | 30.9 |
Dividend Rating | 0.0 |
Rel. Strength | -13.4 |
Analysts | 3.17 of 5 |
Fair Price Momentum | 9.91 USD |
Fair Price DCF | 4.54 USD |
PATH Dividends
Currently no dividends paidPATH Growth Ratios
Growth Correlation 3m | 72.9% |
Growth Correlation 12m | -1% |
Growth Correlation 5y | -72.2% |
CAGR 5y | -32.96% |
CAGR/Max DD 5y | -0.37 |
Sharpe Ratio 12m | -0.09 |
Alpha | -19.47 |
Beta | 1.411 |
Volatility | 47.92% |
Current Volume | 8327.1k |
Average Volume 20d | 8421.8k |
As of July 03, 2025, the stock is trading at USD 12.85 with a total of 8,327,090 shares traded.
Over the past week, the price has changed by +3.05%, over one month by +2.88%, over three months by +18.76% and over the past year by -0.85%.
Neither. Based on ValueRay´s Fundamental Analyses, Uipath is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.90 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PATH is around 9.91 USD . This means that PATH is currently overvalued and has a potential downside of -22.88%.
Uipath has received a consensus analysts rating of 3.17. Therefor, it is recommend to hold PATH.
- Strong Buy: 3
- Buy: 1
- Hold: 18
- Sell: 1
- Strong Sell: 1
According to our own proprietary Forecast Model, PATH Uipath will be worth about 11.9 in July 2026. The stock is currently trading at 12.85. This means that the stock has a potential downside of -7.47%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 14.3 | 11.3% |
Analysts Target Price | 14.1 | 9.4% |
ValueRay Target Price | 11.9 | -7.5% |